Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares and votes in Starbreeze AB

STOCKHOLM, SWEDEN 29 October 2021 – Starbreeze AB today announces that the number of Class B shares increased by 2,220 and the number of Class A shares decreased by the same number during October due to the company’s ongoing conversion program. The number of votes decreased by 19,980.  In accordance with the articles of association Class A shares shall, upon request of the holder of such shares, be converted into Class B shares. In October 2,220 Class A shares were converted into Class B shares, which did not change the total number of shares but reduced the number of votes. As of 31

Conversion of Nightingale Health Plc’s Series A shares and EMP shares to Series B shares

Company release29 October 2021 at 3:00 p.m. (EEST) The Board of Directors of Nightingale Health Plc has in its meeting on September 30, 2021 and October 7, 2021, approved request of shareholders to convert 538,006 Series A shares and 454,054 EMP shares of Nightingale Health Plc to Series B shares in accordance with Article 5 in the Articles of Association. As a result of conversion of shares, the number of the Company’s Series A shares is 22,179,668, Series B shares is 37,219,489 and EMP shares is 1,482,580. The conversion does not affect the total amount of shares which is 60,881,

Eevia Health Plc received new sales orders for organic pine bark extract

Eevia Health Plc, (”Eevia” or ”The Company”), announces that it has received sales orders from a leading organic supplement brand for supply of the Fenoprolic® 70 Organic (organic pine bark extract). The sales value of this start order is c.65,000 EUR, but the customer has a strong record on new product launches, and it is therefore expected to create repeat sales of this product going forward.Eevia exhibited at the trade show “Supply Side West” in Las Vegas this week (25-28.10.21). In connection to this exhibit Eevia received a start order for EUR 65,000 worth of Fenoprolic® 70 Organic (

The Finnish Financial Supervisory Authority has approved a supplement to the merger prospectus concerning the combination of Neles Corporation and Valmet Oyj

Neles Corporation's stock exchange release, 29 October 2021 at 2:30 p.m. EETNOT FOR PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA, SINGAPORE, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial Supervisory Authority has

The Finnish Financial Supervisory Authority has approved a supplement to the merger prospectus concerning the combination of Valmet Oyj and Neles Corporation

The Finnish Financial Supervisory Authority has approved a supplement to the merger prospectus concerning the combination of Valmet Oyj and Neles Corporation   Valmet Oyj’s stock exchange release on October 29, 2021 at 2:30 p.m. EEST NOT FOR PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA, SINGAPORE, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR

Assemblin acquires Finnish electrical contractor Eltex Sähkö ja Automaatio Oy

Assemblin in Finland has acquired all of the shares in Eltex Sähkö ja Automaatio Oy (“Eltex”) with 25 employees and annual sales of approximately EUR 2 million. The acquisition further strengthens Assemblin’s electrical and automation expertise in Finland.Founded in 2005, Eltex is a company that specialises in electrical work for automation projects and has offices in Helsinki. The company began as a regular company of electricians but has now switched focus to working almost exclusively with automation projects. Eltex works for Finland’s leading system suppliers and has been involved in a

Catena acquires logistics land in the Municipality of Bjuv

Catena has acquired 565,000 m[2] of attractive logistics land from a private landowner in the Municipality of Bjuv.29 October 2021, 1.00 p.m. The acquired property, Vrams Gunnarstorp 1:15 in the Municipality of Bjuv, occupies an excellent logistics location adjacent to the E4 motorway and with quick access to the E6 motorway. The acquisition facilitates construction of sustainable and efficient logistics facilities with an estimated lettable area of slightly more than 240,000 m[2] for an investment of approximately SEK 2 billion in the longer term. The plot concerned is located close to

AAK’s Interim report for the third quarter 2021 – all-time high operating profit despite demanding macro-economic climate

AAK Group · Total volumes increased by 3 percent, to 583,000 MT (565,000). · Operating profit, including a negative currency translation impact of SEK 35 million, increased by 7 percent, reaching SEK 642 million (602). · Profit for the period amounted to SEK 464 million (436). · Earnings per share amounted to SEK 1.80 (1.69). · Cash flow from operating activities amounted to negative SEK 20 million (482). · Return on Capital Employed (ROCE), R12M, was 15.5 percent (14.2 at December 31, 2020).   Business areas · Food Ingredients – operating profit increased by

Securitas AB Interim Report January–September 2021

JULY–SEPTEMBER 2021 · Total sales MSEK 27 338 (26 501) · Organic sales growth 4 percent (0) · Operating income before amortization MSEK 1 605 (1 327) · Operating margin 5.9 percent (5.0) · Items affecting comparability (IAC) MSEK –120 (–112), relating to the previously announced transformation programs, the cost-savings program in the Group and a one-off payment from AFA Insurance of MSEK 114 · Earnings per share SEK 2.59 (2.08) · Earnings per share, before IAC, SEK 2.82 (2.31) · Cash flow from operating activities 75 percent (199) JANUARY–SEPTEMBER 2021 ·

InCoax Networks AB (publ) publishes appointed Nomination Committee

The InCoax Networks AB Nomination Committee should consist of four members with one representative from each of the three largest shareholders as of September 30th that wish to nominate a member and the Chairman of the Board.The Nomination Committee has now been appointed and consists of; Stefan Engström representing Saugatruck Invest AB, Anders Nilsson representing Norrlandspojkarna AB, Lars Berggren representing BLL Invest AB and Peter Agardh in his capacity as Chairman of the Board. The Nomination Committee shall prepare proposals in the following matters to be submitted to the Annual

Iridium Network invests in RayCare to become their primary oncology information system

RaySearch and Iridium Network are expanding their clinical partnership as the hospital now aims to implement RayCare®* as their only oncology information system for all their linacs and at all their centers. Iridium Network operates ten Varian®** linacs in four clinics distributed over the Antwerp region and is the only provider of radiation oncology care for the larger Antwerp region in Belgium with over 6,000 new patients per year.Iridium Network has strongly contributed to the development of RayCare and in February 2018 it became the first hospital in the world to clinically use RayCare,

Hamlet Pharma secures Alpha1H production for continued clinical trials

It is a great pleasure to announce that Hamlet Pharma has secured the production of larger quantities of Alpha1H, using a stable, large scale manufacturing process. The new batches will be essential to extend the clinical trial program in patients with bladder cancer.The clinical trial program in bladder cancer is proceeding according to plan, using Alpha1H secured from previous production rounds. Larger amounts of Alpha1H will be needed moving forward, as the clinical trial program is expanding to involve larger patient numbers. As previsously announced, Hamlet Pharma is collaborating

Ingka Group thanks co-workers for efforts during pandemic with EUR 110 million gift

Ingka Group, the largest IKEA retailer, has announced it will award all co-workers around the globe a total of EUR 110 million to recognise their extraordinary efforts during the Covid pandemic.“Since the early stage of the pandemic, we have strived to support our co-workers in a professional and caring manner, in line with our values and humanistic approach, and this is another step in that direction,” says Ulrika Biesèrt, People & Culture manager at IKEA Retail (Ingka Group).   Biesèrt says Ingka Group has overcome incredible challenges, shown how adaptable it could be, and how

Read original

Lagercrantz acquires Geonor AS

Lagercrantz Group has today acquired all shares in the Norwegian company Geonor AS.Geonor manufactures and sells geotechnical, hydrological, meteorological and environmental equipment and solutions to a broad customer base in Norway and internationally. Geonor is based in Østerås in the Oslo area in Norway and generates annual revenue of approximately MNOK 30 with good profitability. For a presentation of the company, please visit www.geonor.no. ”Lagercrantz supports the development of companies with internationally leading products. With our hubs in Europe, Asia and in North America we

The Pneumatic Actuator and Positioner: GF Piping Systems adds further award-winning innovation to its process automation family

The Red Dot Design Award-winning product design manufactured with recyclable composite materials and new sizing options builds further strength into GF's process automation family while significantly contributing to the corporation's sustainability goal of achieving 70% of sales with social and environmental benefits.The innovative Pneumatic Actuator and Positioner offer a pneumatic valve pack with a lifetime as long as the entire piping system. Designed for multiple industries, including microelectronics, marine, and chemical processing, both innovations' highly chemical resistant material

Evac appoints Björn Ullbro to lead its new Marine & Offshore business area

Björn Ullbro has been appointed President, Marine & Offshore business area at Evac Group. Björn joins Evac from Wärtsilä, where he has worked in multiple roles and continents over the past 13 years, the most recently as Vice President for Wärtsilä’s energy business in Africa and Europe.“I am excited to welcome Björn to Evac. He is a respected people leader with deep sales, strategy and business development experience in complex project and service businesses. As market activity and interest towards our sustainable solutions are accelerating, we want to ensure that our commercial leadership,

Invitation to presentation of LMK Group’s Q3 2021 interim report

LMK Group will publish its Q3 2021 interim report on 9 November 2021 at 07:45 CET. In connection with this, LMK Group invites investors, analysts and media to a conference call and webcast on the same day at 09:00 CET.The presentation will be held by CEO Walker Kinman and CFO Erik Bergman in English and will conclude with a Q&A session. Questions can be asked on the telephone conference or in written form through the webcast. No preregistration is required. Date and time9 November 2021 at 09:00 CET Webcasthttps://tv.streamfabriken.com/lmk-group-q3-2021 Phone numberTo

Swedavia AB (publ) considers hybrid bond issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BY UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.Swedavia AB (publ) is assessing market conditions for issuing new Swedish kronor-denominated hybrid capital.The aim of the transaction is to provide the best possible financial flexibility in the execution of Swedavia's strategy and mission, whilst securing Swedavia's capital structure objectives. Nordea and Swedbank

Fondia Plc: growth continues – expansive recruiting decreased profitability on third quarter

Unofficial translation Fondia Plc Company release published on October 29[th] 2021 at 8:30. Quarterly report July – September 2021 The company complies with the half year reports required by the Securities Markets Act and publishes quarterly reports for the first three and the first nine months of the year, which present key information describing the company’s financial development. The financial information presented in this quarterly report is unaudited. Financial development in July – September and January – September 2021. GROUP

Invitation to the webcast on Fortum's January−September 2021 Interim Report

FORTUM CORPORATION INVESTOR NEWS 29 OCTOBER 2021 AT 12:00 EEST Fortum's January−September 2021 Interim Report will be published on 12 November 2021 at approximately 9:00 EET. A combined live webcast/teleconference for media, investors, and analysts will be arranged online on the same day at 11:00 EET. For the webcast, use the link on www.fortum.com/investors. To participate in the teleconference and Q&A, dial in using the numbers below: FI: +358 9 817 10310UK: +44 333 300 0804US: +1 631 913 1422 PIN: 92145400# A recording of the webcast as well as the transcript will

OXE Marine AB (publ) Interim report 1 July to 30 September 2021

OXE Marine AB (publ) (NASDAQ STO: OXE) (OTCQX: CMMCF) Interim report Third quarter (July - September 2021) · Net turnover of SEK 26.2m (SEK 3.4m) · Gross Profit of SEK 7.3m (SEK 0.8m) or gross margin of 28% (24%) · Operating Loss/EBIT of SEK -12.8m (SEK -25.1m) · Result for the period of SEK -15.2m (SEK -27.3m) · Order book amounted to EUR 11.1m or SEK 113m at the end of the quarter. January – September 2021 · Year to date net turnover of SEK 58.0m (SEK 34.9m) · Gross Profit of SEK 15.9m (SEK 4.4m) or gross margin of 27% (13%) · Operating Loss/EBIT of

Swedavia's Q3 2021 report: Positive cash flow thanks to increased travel and good cost control

During the third quarter, traffic at Swedavia's airports increased as countries have opened up and travel restrictions have been eased. Net revenue totalled 793 million Swedish kronor, more than 70 per cent higher compared to a year ago, and cash flow from operating activities, excluding State aid, was positive for the first time since the start of the pandemic. Despite these positive signs, the market situation remains uncertain, and Swedavia reported a loss for the sixth straight quarter, with an operating loss of 250 million kronor.During the third quarter, nearly 4.4 million passengers

Veg of Lund’s Nomination Committee for the 2022 Annual General Meeting

The members of the Nomination Committee ahead of the 2022 Annual General Meeting of Veg of Lund AB (publ) have been appointed. The Nomination Committee shall consist of four members, in addition to the Chairman of the Board, representatives of the three largest shareholders in terms of votes who wish to participate in the Nomination Committee.The members of the Nomination Committee ahead of the 2022 Annual General Meeting are: Kaj Söderström, representing Reosurf AB, Chairman of the Nomination Committee, Anders Hättmark, representing Confidera Syd Aktiebolag, Torbjörn Malmsjö and Torbjörn

BioStock: Ultimovacs launches fifth phase II trial with UV1

Norwegian Ultimovacs continues to expand its clinical development pipeline with universal cancer vaccine UV1. This week, the company announced its plan to initiate a fifth phase II trial with the candidate – a combination study with checkpoint inhibitor pembrolizumab in non-small cell lung cancer. The study will be conducted at 8-10 sites across Norway and led by principal investigator Professor Odd Terje Brustugun.Read the article at biostock.se : https://www.biostock.se/en/2021/10/ultimovacs-launches-fifth-phase-ii-trial-with-uv1/ This is a press release

There are no items matching the current filter
There are no more items matching the current filter
Back to top